Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03833804 · ClinicalTrials.gov registry record · NA
Data-driven Identification for Substance Misuse
A NA study of Substance Use and Substance-Related Disorders, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 64,996
- Enrollment target
- 1
- Study location
NCT03833804: Completed NA study of Substance Use and Substance-Related Disorders, sponsored by University of Wisconsin, Madison.
NCT03833804 is a NA study of Substance Use and Substance-Related Disorders that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 64,996 participants, above the 522-participant average among 88 other Substance Use trials with a reported enrollment target (12351% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03833804, a NA study of Substance Use and Substance-Related Disorders, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 64,996 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose to develop an open-source, publicly available machine learning model that health systems could download and apply to their electronic health record data marts to screen for substance misuse in their patients. The investigators hypothesize that the natural language processing algorithm can provide a standardized and interoperable approach for an automated daily screen on all hospitalized patients and provide better implementation fidelity for screening, brief intervention, and referral to treatment.
Primary Outcome
The primary outcome is the proportion of patients who received SBIRT after a positive universal screen for being at risk for substance misuse. The design is an interrupted time-series prospective observational study.
Conditions Studied
Interventions
- OTHER Processing of clinical notes in the EHR data collected during routine care
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64,996 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2024-09-19 |
| Phase | NA |
What the finished NCT03833804 record still lists
NCT03833804 is an interventional study that assigns participants to a tested intervention. Its 64,996 participants enrollment target places it among the larger protocols in the corpus, above the 522-participant average among 88 other Substance Use trials with a reported enrollment target (12351% higher).
The record links to 3 conditions, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which Processing of clinical notes in the EHR data collected during routine care is the first listed.
NCT03833804 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03833804 about?
NCT03833804 is a clinical study titled "Data-driven Identification for Substance Misuse". The investigators propose to develop an open-source, publicly available machine learning model that health systems could download and apply to their electronic health record data marts to screen for substance misuse in their patients. The investigators hypothesize that the natural language processin...
What is the current status of trial NCT03833804?
This trial is currently completed. It is a NA study. The enrollment target is 64,996 participants. The study started on 2022-09-19. Estimated completion is 2024-09-19.
What conditions does trial NCT03833804 study?
This clinical trial studies the following conditions: Substance Use, Substance-Related Disorders, Substance Abuse.
What interventions are being tested in trial NCT03833804?
The interventions under investigation include: Processing of clinical notes in the EHR data collected during routine care (OTHER).
Who is sponsoring clinical trial NCT03833804?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03833804 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03833804's enrollment target sits among peer trials
64,996 1st of 88 higher than 88 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04473833 · 65,000 participants · NA
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- NCT05128006 · 63,200 participants
Direct-to-patient Teledermatology and Computer-assisted Diagnosis
- NCT06003192 · 63,000 participants · NA
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
- NCT00009633 · 68,000 participants
Follow-up Visit of High Risk Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI